A detailed history of Cornercap Investment Counsel Inc transactions in Incyte Corp stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 28,739 shares of INCY stock, worth $1.66 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
28,739
Previous 15,846 81.36%
Holding current value
$1.66 Million
Previous $994,000 64.69%
% of portfolio
0.26%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$56.55 - $66.59 $729,099 - $858,544
12,893 Added 81.36%
28,739 $1.64 Million
Q4 2023

Jan 30, 2024

BUY
$52.16 - $64.19 $826,527 - $1.02 Million
15,846 New
15,846 $994,000
Q3 2021

Nov 15, 2021

SELL
$68.67 - $84.02 $2.12 Million - $2.59 Million
-30,823 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$79.87 - $87.53 $2.46 Million - $2.7 Million
30,823 New
30,823 $2.59 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $12.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.